Company Overview

Prescient NeuroPharma is a Canadian biopharmaceutical company that is engaged in the development and commercialization of novel therapeutic products to treat cancer and CNS diseases. Prescientis achieving its objectives in these areas through its three operational divisions: Cancer Drugs, CNS Drugs, and Fine Chemicals.

Cancer - Discovery and clinical development of new anti-cancer drugs with enhanced therapeutic properties by rational drug design and medicinal chemistry. The core cancer therapeutic technology was discovered at the University of British Columbia and is being commercially developed by IGT.

CNS Disease - Discovery and clinical development of novel therapeutics for the treatment of disorders of the brain utilizing capabilities of medicinal chemistry, combinatorial chemistry and molecular targeting. The therapeutic technology is based on metabotropic glutamate receptor pharmacology.

Fine Chemicals - A provider of leading edge chemicals and services to the biotechnology and pharmaceutical industries worldwide. This division provides Prescient with sales revenue.

Company Information

Additional Details

Legal Name: Prescient Neuro Pharma Inc..

Number of Employees: 13

Contacts

Services

• Biotechnology

Products

• Anhydrovinblastine

NAICS Categories

• 414510 Pharmaceuticals and Pharmacy Supplies Wholesaler-Distributors
• 541710 Research and Development in the Physical, Engineering and Life Sciences

Additional Information